Mel

I could not really find a reason in the article why there were more deaths reported.

They stated they could not link it to Avandia or really to any major difference in that protocol, other than the more aggressive goal.

The above referenced article states only:

“A thorough review of the data shows that the medical treatment strategy of intensively reducing blood sugar below current clinical guidelines causes harm in these especially high-risk patients with type 2 diabetes,” said Dr. Elizabeth G. Nabel, director of the institute.

It was very vague. I am sure more articles will come out explaining it better.